Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6287928

NCCC[C@H](NC(=O)Cc1c[nH]c2ccccc12)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@H](CCCN)NC(=O)Cc3c[nH]c4ccccc34)cc2)c2ccc(NC(=O)[C@H](CCCN)NC(=O)Cc3c[nH]c4ccccc34)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
PTBP1 P26599 1/20 0.46
HTT P42858 1/20 0.46
HDAC1 Q13547 4/20 0.46
HDAC3 O15379 3/20 0.46
HDAC4 P56524 3/20 0.46
HDAC7 Q8WUI4 3/20 0.46
HDAC2 Q92769 3/20 0.46
HDAC10 Q969S8 3/20 0.46
HDAC11 Q96DB2 3/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC9 Q9UKV0 3/20 0.46
HDAC5 Q9UQL6 3/20 0.46
KDM1A O60341 1/20 0.45
MAOA P21397 1/20 0.45
MC4R P32245 2/20 0.44
MC3R P41968 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6290840 0.97 LMNA (0.46) SMN1; SMN2MAPTLMNAPTBP1HTT
Trifluoroacetic Acid SCHEMBL6288009 0.95 SMN1; SMN2 (0.47) SMN1; SMN2MAPTLMNAPTBP1HTT
Trifluoroacetic Acid SCHEMBL6290374 0.91 SMN1; SMN2 (0.49) SMN1; SMN2MAPTLMNAPTBP1HTT
Hydrochloric Acid SCHEMBL6286774 0.90 HDAC1 (0.49) SMN1; SMN2HDAC1HDAC3HDAC4HDAC7
Hydrochloric Acid SCHEMBL6290968 0.90 HDAC1 (0.49) SMN1; SMN2HDAC1HDAC3HDAC4HDAC7
SCHEMBL7038483 0.88 HDAC1 (0.49) SMN1; SMN2MAPTLMNAPTBP1HTT
Trifluoroacetic Acid SCHEMBL6284172 0.88 GHSR (0.45) SMN1; SMN2MAPTLMNAPTBP1HTT
SCHEMBL6284142 0.85 HDAC1 (0.50) SMN1; SMN2MAPTHDAC1HDAC3HDAC4
SCHEMBL6287930 0.84 LMNA (0.46) SMN1; SMN2MAPTLMNAPTBP1HTT
Trifluoroacetic Acid SCHEMBL6287362 0.84 LMNA (0.49) SMN1; SMN2MAPTLMNAPTBP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK SMN1; SMN2 1648/4885MAPT 4866/4885LMNA 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.